N.D. Admin. Code 33.1-24-05-311 : Department of Environmental Quality —24 - Hazardous Waste Management —24-05 - Standards for Treatment, Storage, and Disposal Facilities and for the Management of Specific Hazardous Wastes and Specific Types of Hazardous Waste Management Facilities —MISCELLANEOUS UNITS —24-05-311 - Applicability
1. A health care facility that is a very small quantity generator when counting all of its hazardous waste, including both its hazardous waste pharmaceuticals and its nonpharmaceutical hazardous waste, remains subject to section
33.1-24-03-26 and is not subject to sections
33.1-24-05-310 through
33.1-24-05-320, except for sections
33.1-24-05-315 and
33.1-24-05-317, and the optional provisions of section
33.1-24-05-314.
2. A health care facility that is a very small quantity generator when counting all of its hazardous waste, including both its hazardous waste pharmaceuticals and its nonpharmaceutical hazardous waste, has the option of complying with subsection 4 for the management of its hazardous waste pharmaceuticals as an alternative to complying with section
33.1-24-03-26 and the optional provisions of section
33.1-24-05-314.
3. A health care facility or reverse distributor remains subject to all applicable hazardous waste regulations with respect to the management of its nonpharmaceuticals hazardous waste.
4. With the exception of health care facilities identified in subsection 1, a health care facility is subject to the following in lieu of
33.1-24-03 and
33.1-24-04, and sections
33.1-24-05-01 through
33.1-24-05-190,
33.1-24-05-300 through
33.1-24-05-309,
33.1-24-05-400 through
33.1-24-05-524,
33.1-24-05-550 through
33.1-24-05-559, and
33.1-24-05-800 through
33.1-24-05-819:
a. Sections
33.1-24-05-312 and
33.1-24-05-315 through
33.1-24-05-318 with respect to the management of:
(1) Noncreditable hazardous waste pharmaceuticals; and
(2) Potentially creditable hazardous waste pharmaceuticals if they are not destined for a reverse distributor.
b. Subsection 1 of section
33.1-24-05-312, section
33.1-24-05-313, sections
33.1-24-05-315 through
33.1-24-05-317, and section
33.1-24-05-319 with respect to the management of potentially creditable hazardous waste pharmaceuticals that are prescription pharmaceuticals and are destined for a reverse distributor.
5. A reverse distributor is subject to sections
33.1-24-05-310 through
33.1-24-05-320 in lieu of
33.1-24-03 and
33.1-24-04, and sections
33.1-24-05-01 through
33.1-24-05-190,
33.1-24-05-300 through
33.1-24-05-309,
33.1-24-05-400 through
33.1-24-05-524,
33.1-24-05-550 through
33.1-24-05-559, and
33.1-24-05-800 through
33.1-24-05-819 with respect to the management of hazardous waste pharmaceuticals.
6. Hazardous waste pharmaceuticals generated or managed by entities other than health care facilities and reverse distributors, e.g., pharmaceutical manufacturers and reverse logistics centers, are not subject to sections
33.1-24-05-310 through
33.1-24-05-320. Other generators are subject to
33.1-24-03 for the generation and accumulation of hazardous wastes, including hazardous waste pharmaceuticals.
7. The following are not subject to
33.1-24-01 through
33.1-24-07 except as specified:
a. Pharmaceuticals that are not solid waste, as defined by section
33.1-24-02-02, because they are legitimately used or reused, e.g., lawfully donated for their intended purpose, or reclaimed.
b. Over-the-counter pharmaceuticals, dietary supplements, or homeopathic drugs that are not solid wastes as defined by section
33.1-24-02-02 because they have a reasonable expectation of being legitimately used or reused, e.g., lawfully redistributed for their intended purpose, or reclaimed.
c. Pharmaceuticals being managed in accordance with a recall strategy that has been approved by the food and drug administration in accordance with title 21, Code of Federal Regulations, part 7, subpart C. This subpart does apply to the management of the recalled hazardous waste pharmaceuticals after the food and drug administration approves the destruction of the recalled items.
d. Pharmaceuticals being managed in accordance with a recall corrective action plan that has been accepted by the consumer product safety commission in accordance with title 16, Code of Federal Regulations, part 1115. Sections
33.1-24-05-310 through
33.1-24-05-320 do not apply to the management of the recalled hazardous waste pharmaceuticals after the consumer product safety commission approves the destruction of the recalled items.
e. Pharmaceuticals stored according to a preservation order, or during an investigation or judicial proceeding until after the preservation order, investigation, or judicial proceeding, has concluded or a decision is made to discard the pharmaceuticals.
f. Investigational new drugs for which an investigational new drug application is in effect in accordance with the food and drug administration's regulations in title 21, Code of Federal Regulations, part 312. Sections
33.1-24-05-310 through
33.1-24-05-320 apply to the management of the investigational new drug after the decision is made to discard the investigational new drug or the food and drug administration approves the destruction of the investigational new drug, if the investigational new drug is a hazardous waste.
g. Household waste pharmaceuticals, including those that have been collected by an authorized collector, as defined by the drug enforcement administration, provided the authorized collector complies with the conditional exemption in subdivision a of subsection 1 of section
33.1-24-05-316 and subsection 2 of section
33.1-24-05-316.
N.D. Admin Code 33.1-24-05-311
Reserved by Administrative Rules Supplement 370, October 2018, effective 1/1/2019.
Amended by Administrative Rules Supplement 2021-381, July 2021, effective 7/1/2021.